Viscogliosi Brothers

Founded by Anthony, John, and Marc Viscogliosi in 1999, the firm creates, builds, operates, and finances companies founded on surgeon-developed innovation to address unmet clinical needs, uniquely focused on life-changing neuromusculoskeletal technologies. VB principals have participated in more than 200 transactions, invested in more than 20 companies, and have formed nine industry-defining strategic partnerships. ​ VB invests in technologies whose applications benefit patients and the healthcare system by improving the quality of care, reducing costs, and expanding patient and provider access. With enhanced data, VB attempts to identify the technologies that best satisfy these criteria and works to transform them into successful medical breakthroughs that enable patients to regain active lifestyles. VB, its affiliates, and its partnerships have generated more than $1.5 billion in exit value on behalf of their shareholders and investor base. Through its portfolio companies, VB has defined five entirely novel orthopedic industry categories. Its investments have helped commercialize more than 75 med-tech devices, including ten number one orthopedic technologies. VB portfolio companies have sold products in more than 70 countries.